1. Home
  2. ZLAB vs LMAT Comparison

ZLAB vs LMAT Comparison

Compare ZLAB & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

HOLD

Current Price

$25.65

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo LeMaitre Vascular Inc.

LMAT

LeMaitre Vascular Inc.

HOLD

Current Price

$79.05

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZLAB
LMAT
Founded
2013
1983
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.1B
IPO Year
2017
2006

Fundamental Metrics

Financial Performance
Metric
ZLAB
LMAT
Price
$25.65
$79.05
Analyst Decision
Strong Buy
Buy
Analyst Count
5
5
Target Price
$49.60
$105.80
AVG Volume (30 Days)
818.3K
240.6K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
0.93%
EPS Growth
38.46
30.57
EPS
N/A
1.42
Revenue
$460,156,000.00
$249,602,000.00
Revenue This Year
$9.75
$14.21
Revenue Next Year
$26.03
$8.88
P/E Ratio
N/A
$55.96
Revenue Growth
15.33
13.53
52 Week Low
$15.96
$78.27
52 Week High
$34.72
$118.01

Technical Indicators

Market Signals
Indicator
ZLAB
LMAT
Relative Strength Index (RSI) 56.31 37.39
Support Level $24.81 $78.65
Resistance Level $27.22 $83.71
Average True Range (ATR) 0.90 1.82
MACD -0.23 0.46
Stochastic Oscillator 51.30 15.69

Price Performance

Historical Comparison
ZLAB
LMAT

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.

Share on Social Networks: